Article

Technique enables surgical success in intrao;perative iris floppy system

The combination of 1.8-mm coaxial microincision cataract surgery, proper wound construction, and attention to other elements of a surgical technique aiming to maintain chamber stability allows safe and effective cataract surgery in eyes with IFIS without the need for pupil expansion.

Dr. Hunkeler described his personal experience performing 1.8-mm C-MICS with linear phacoemsulfication using a proprietary phacoemulsification system (Stellaris Vision Enhancement System, Bausch + Lomb) in a presentation at the annual meeting of the European Society of Cataract and Refractive Surgeons.

Key components of his technique include the creation and maintenance of snug trapezoidal incisions, use of a smaller capsulorhexis than usual, and a divide-and-conquer approach.

"The divide-and-conquer technique keeps the phaco tip behind the iris during nuclear disassembly to reduce the likelihood of iris trauma," he said. "Nuclear fragments are elevated into the anterior chamber by the phaco tip in aspiration mode for subsequent ultrasound removal, well away from the iris. 1.8-mm C-MICS with the [phaco] platform delivers reliable control of both phaco power and vacuum to maintain excellent chamber stability."

Less need for expansion devices

"Using this procedure I have been able to perform cataract surgery safely and successfully in eyes with IFIS, with no iris or capsule complications and without the need for pupil expansion devices in most cases," Dr. Hunkeler added.

He reported that in 2008, when performing 2.8-mm coaxial phaco, he placed a pupil expansion device (Malyugin ring, MicroSurgical Technology) in 33% of IFIS cataract surgery cases. In 2009, his usage of the device in IFIS cases decreased to 9%, but those cases were mostly performed during the first half of the year.

"Since August 2009, I have only used the ring in a single IFIS cataract surgery case," he said.

Trapezoidal incision, paracentesis

Dr. Hunkeler said he creates a clear corneal trapezoidal incision and a trapezoidal paracentesis, employing a paracentesis blade first to create the primary incision and then a triangular blade to create the trapezoidal component.

He said he also instills Shugarcaine and Amvisc Plus to help maintain maximum pupillary dilation throughout the procedure.

Using the divide-and-conquer technique, because it reduces the possibility of iris prolapse, he performs as much sculpting and cracking as possible in the posterior chamber before elevating the lens material to just above the pupillary plane, where it is removed with C-MICS phaco and irrigation/aspiration.

Once lens removal is completed, viscoelastic is instilled into the posterior chamber, and Dr. Hunkeler implants a spherical, aberration-free microincision lens (Akreos MICS IOL, Bausch + Lomb) through the 1.8-mm clear corneal incision.

FYI

John D. Hunkeler, MD
E-mail: jhunkeler@hunkeler.com

Dr. Hunkeler is a consultant to Abbott Medical Optics and Bausch + Lomb.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.